Could rhG-CSF induction of tetraploidy contribute to leukemogenesis in healthy donors? [3]

British Journal of Haematology

Volumn 138, Issue 4, 2007, Pages 558-

  Kaplinsky, C ^a   Trakhtenbrot, L ^a   Izraeli, S ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bone marrow transplantation; Leukaemia; rhG CSF; Tetraploidy

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

BONE MARROW CELL; CARCINOGENICITY; CELL DIVISION; CELL MATURATION; CELL STRUCTURE; DNA REPLICATION; GENETIC RISK; HUMAN; LETTER; LEUKEMIA; LEUKEMOGENESIS; ORGAN DONOR; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SEX CHROMOSOME; TETRAPLOIDY;

BLOOD DONORS; CELL CYCLE; DISEASE SUSCEPTIBILITY; FILGRASTIM; HUMANS; LEUKEMIA; PLOIDIES;

EID: 34447300689     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06685.x     Document Type: Letter

References (7)

1. Bennett, C.L., Evens, A.M., Andritsos, L.A., Balasubramanian, L., Mai, M., Fisher, M.J., Kuzel, T.M., Angelotta, C., McKoy, J.M., Vose, J.M., Bierman, P.J., Kuter, D.J., Trifilio, S.M., Devine, S.M. Tallman, M.S. (2006) Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. British Journal of Haematology, 135, 642 650.
2. Confer, D.L. Miller, J.P. (2007) Long-term safety of filgrastim (rhG-CSF) administration. British Journal of Haematology, 137, 77 78 author reply 79-80.
3. Ganem, N.J., Storchova, Z. Pellman, D. (2007) Tetraploidy, aneuploidy and cancer. Current Opinion in Genetics and Development, 17, 157 162.
4. Kaplinsky, C., Lotem, J. Sachs, L. (1996) Protection of human myeloid leukemic cells against doxorubicin-induced apoptosis by granulocyte-macrophage colony-stimulating factor and interleukin 3. Leukemia, 10, 460 465.
5. Kaplinsky, C., Trakhtenbrot, L., Hardan, I., Reichart, M., Daniely, M., Toren, A., Amariglio, N., Rechavi, G. Izraeli, S. (2003) Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF. Bone Marrow Transplantation, 32, 31 34.
6. Pellman, D. (2007) Cell biology: aneuploidy and cancer. Nature, 446, 38 39.
7. Sotillo, R., Hernando, E., Diaz-Rodriguez, E., Teruya-Feldstein, J., Cordon-Cardo, C., Lowe, S.W. Benezra, R. (2007) Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell, 11, 9 23.